Concourse Financial Group Securities’s Virpax Pharmaceuticals, Inc. Common Stock VRPX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 10404 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 10681 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 10585 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 10427 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 10279 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 10042 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 9795 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 9574 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 9214 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 9223 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 9027 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 8857 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 8653 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 8340 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 7885 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 7513 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 7182 |
|